Terraflora Daily Care and Gastrointestinal Health

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Gastrointestinal

In brief

A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.

Key facts

Study ID

NCT07355634

Run by

OvationLab

People needed

40

Starts

2026-01-12

Expected to finish

2026-09-01

Last updated by the study team

2026-05-11

Who can join

Age: 25 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult males or females age ≥ 25 years
• Ability to read and speak English
• Dysbiosis (≥3 on GA-Map Dysbiosis Score) on a stool test (GI360 Profile, Doctor's Data, St. Charles, Illinois)

You may not qualify if…

• Daily use within the past month of any probiotic or prebiotic supplement
• Current diagnosis of inflammatory bowel disease, including Crohn's or ulcerative colitis
• Current daily usage of non-steroidal anti-inflammatory drugs (NSAID), proton pump inhibitors (PPI), or antibiotic medications
• Current daily tobacco smoker
• Known allergies to any substance in the study products
• Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
• Current diagnosis of any other chronic health condition (e.g., cancer, chronic kidney disease) deemed clinically contraindicated for the study protocol
• Current participation in another clinical trial
• Participants unable to provide consent

Where it is running

• OvationLab — Richmond, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.